Diabetic ketoacidosis
MONDO:0012819The metabolic condition resulted from uncontrolled diabetes mellitus, in which the shift of acid-base status of the body toward the acid side because of loss of base or retention of acids other than carbonic acid is accompanied by the accumulation of ketone bodies in body tissues and fluids.
Also known as: KPD
53 clinical trials for this condition and its sub-types, 22 tagged with Diabetic ketoacidosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
-
New study aims to reduce DKA risk for type 1 diabetes patients using SGLT2 inhibitors
Disease control Not yet recruitingThis study tests whether a special education plan using continuous ketone monitoring can lower the risk of diabetic ketoacidosis (DKA) in people with type 1 diabetes who also take SGLT2 inhibitors, a drug class that raises DKA risk. About 75 adults with type 1 diabetes will be en…
Phase 2 • Sponsor: AdventHealth Translational Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Can a tiny implant track glucose, ketones, and lactate in diabetes?
Diagnosis Not yet recruitingThis trial is testing a new implantable sensor called the HALO System in people with type 1 or type 2 diabetes. The sensor is designed to continuously measure glucose, ketones, and lactate in the fluid just beneath the skin, which could give a more complete picture of metabolic h…
Sponsor: Indigo Diabetes NV • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
A routine blood count may reveal how severe diabetic ketoacidosis will be
Knowledge-focused Not yet recruitingResearchers at Assiut University Hospitals are studying whether a simple calculation from two routine blood tests, the leukocyte glucose index, relates to how severe diabetic ketoacidosis becomes in adults with diabetes. The index multiplies white blood cell count by blood sugar …
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
New study aims to prevent dangerous ketosis in type 1 diabetes patients with kidney disease
Knowledge-focused Not yet recruitingThis study looks at how to safely use a type of diabetes drug (SGLT1&2 inhibitor) in people with type 1 diabetes and mild to moderate chronic kidney disease. The goal is to find out what increases the risk of a serious condition called diabetic ketoacidosis (DKA). About 80 adults…
Phase 2 • Sponsor: HealthPartners Institute • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC